Joshua Pritchett, M.D.

My passion is bringing high-quality cancer care to patients in community care settings. Along with seeing patients in Eau Claire and La Crosse, Wisconsin, I practice at Mayo Clinic in Rochester, Minnesota. In my clinical practice, I am a full-spectrum community oncologist and hematologist with a focus on growth and innovation within community-based cancer care.

My research is centered on the design and implementation of innovative models of cancer care delivery, with a focus on bridging the divide for cancer patients experiencing disparities in access to care - particularly rural populations. Recent work includes the design and implementation of Mayo Clinic’s “DEFeNDR” program — a remote patient monitoring program that leverages digital health to facilitate dynamic and decentralized outpatient management for cancer patients experiencing neutropenic fever. I also co-lead the Stanford University and Mayo Clinic collaborative on telehealth in cancer, and I serve as an advisor with the Rural Cancer Institute.

Education

• University of Minnesota Medical School

Residency

• Internal Medicine, Mayo Clinic School of Graduate Medical Education

Fellowship

• Hematology and Medical Oncology, Mayo Clinic School of Graduate Medical Education

Certifications

• Hematology, American Board of Internal Medicine
• Internal Medicine, American Board of Internal Medicine
• Medical Oncology, American Board of Internal Medicine

Memberships

• American Society of Clinical Oncology
• American Society of Hematology

Academic Appointment

• Assistant Professor of Medicine, Mayo Clinic College of Medicine and Science
• Assistant Professor of Oncology, Mayo Clinic College of Medicine and Science

• Post-pandemic digital health reimbursement in oncology: impact on access to care, June 2025.
• Increasing digital equity to promote online smoking cessation program engagement among rural adults: a randomized controlled pilot trial, October 2024.
• Telehealth utilization in neuro-oncology: commentary on a single institution experience after the COVID-19 pandemic, July 2024.
• The growing role of digital health tools in the care of patients with cancer: current use, future opportunities, and barriers to effective implementation, June 2024.
• Remote patient monitoring to transform management of febrile neutropenia in cancer patients, March 2024.